ProVerum and Zenflow this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia (BPH). Dublin, Ireland-based ProVerum won approval for its ProVee system. Zenflow got the green light for its Spring implant and delivery system. Both companies aim to offer a potential treatment for BPH, a common urological … [Read more...] about ProVerum, Zenflow win FDA nods for BPH treatment devices
ProVerum Medical
ProVerum raises $80M for nitinol stent that treats BPH
ProVerum announced today that it closed an $80 million Series B equity financing to support its device to treat benign prostatic hyperplasia (BPH). MVM Partners led the financing. New investors OrbiMed and the Ireland Strategic Investment Fund (ISIF) also joined in. Existing investors Gilde Healthcare Partners, Lightstone Ventures, Atlantic Bridge … [Read more...] about ProVerum raises $80M for nitinol stent that treats BPH
ProVerum completes enrollment in ProVIDE clinical study for ProVee BPH treatment device
ProVerum this week announced it completed enrollment in its ProVIDE pivotal clinical trial to evaluate the safety and effectiveness of the ProVee system. The ProVIDE clinical trial is a prospective, multicenter, double-blind controlled study that evaluates the safety, performance, and effectiveness of the ProVee system in patients with lower … [Read more...] about ProVerum completes enrollment in ProVIDE clinical study for ProVee BPH treatment device
